Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al

Affiliations

• ¹ Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
• ² Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital, Birmingham, UK.
• ³ IONTAS Ltd, Cambridge, UK.
• ⁴ Rheumatology Research Group, School of Immunity and Infection, Birmingham, UK.
• ⁵ University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
• ⁶ Nascient, Cambridge, UK.
• ⁷ Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
• ⁸ Department of Rheumatology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
• ⁹ Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK kim.midwood@kennedy.ox.ac.uk.